Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-06 · accession 0001567619-21-018153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-08 | 2021-10-06 | TMCI | Ferguson Joe W. | SVP, Research, Development | M - OptEx | $0.1 | +308.6K | 419.8K | +278% | +$30.9K |
| D | 2021-10-08 | 2021-10-06 | TMCI | Ferguson Joe W. | SVP, Research, Development | M - OptEx | $0.00 | -308.6K | 249.0K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-06 | M | A | 308,641 | $0.1 | 419,756 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-10-06 | M | D | 308,641 | $0.00 | 248,994 | D | $0.1 · — to 2024-07-14 | 308,641 Common Stock | (F1) The stock option is fully vested and exercisable. |